Israel - heprea - Ministry of Health

tzamal bio-pharma ltd - candesartan cilexetil; hydrochlorothiazide - טבליה - candesartan cilexetil 16 mg; hydrochlorothiazide 12.5 mg - candesartan and diuretics - candesartan and diuretics - essential hypertension, where monotherapy with candesartan cilexetil or hydrochlorothiazide is not sufficient.

Israel - heprea - Ministry of Health

unipharm ltd, israel - candesartan cilexetil - טבליה - candesartan cilexetil 16 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated

Israel - heprea - Ministry of Health

unipharm ltd, israel - candesartan cilexetil - טבליה - candesartan cilexetil 8 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated

Israel - heprea - Ministry of Health

tzamal bio-pharma ltd - candesartan cilexetil - טבליה - candesartan cilexetil 4 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Israel - heprea - Ministry of Health

tzamal bio-pharma ltd - candesartan cilexetil - טבליה - candesartan cilexetil 8 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Israel - heprea - Ministry of Health

tzamal bio-pharma ltd - candesartan cilexetil - טבליה - candesartan cilexetil 16 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Israel - heprea - Ministry of Health

unipharm ltd, israel - candesartan cilexetil - טבליה - candesartan cilexetil 16 mg - candesartan

Israel - heprea - Ministry of Health

unipharm ltd, israel - candesartan cilexetil - טבליה - candesartan cilexetil 8 mg - candesartan

Israel - heprea - Ministry of Health

unipharm ltd, israel - candesartan cilexetil; hydrochlorothiazide - טבליה - hydrochlorothiazide 12.5 mg; candesartan cilexetil 16 mg - candesartan

Israel - heprea - Ministry of Health

teva pharmaceutical indust.ltd - candesartan cilexetil 16 mg; hydrochlorothiazide 12.5 mg - tablets - candesartan - essential hypertension, where montherapy with candesartan cilexetil or hydrochlorothiazide is not sufficient.